Company Profile
CalciMedica Stock Price, News & Analysis
- Ticker:
- CALC
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- United States
Stock performance
0.70 USD (-7.45%)
Close
Last updated: July 27, 2026
12.6M USD
Market cap
Why the stock is moving
As of Jul 27, 2026, CALC closed down 7.45% at $0.7033. No new same-company headline was identified in the current news window.
Company overview
Business overview
CalciMedica is a biotechnology company focused on calcium-channel biology and inflammatory disease. Its story centers on using a targeted mechanism to address severe immune-mediated conditions.
Geographic Base and Sector Classification
CalciMedica is headquartered in the United States and listed on NASDAQ. It sits in small-cap immunology biotechnology.
Business Model Characteristics
The company depends on clinical validation, translational confidence, and capital discipline while it advances a focused pipeline. Investors watch early data and safety.
Position Within the Biotechnology Landscape
CalciMedica occupies a niche inflammation pathway position within biotech. The stock is driven by whether its biology can create a real clinical signal.
Future catalysts
CalciMedica’s catalysts are calcium-signaling inflammation programs and any clinical update that clarifies whether the company can still build a viable development story. The next step matters because the story remains early.
Recent news
The five most recent related feed items are shown below in reverse chronological order.
- 01
Kymera Therapeutics Appoints Terence Rooney, MD, as Chief Medical Officer
KYMR · Source: Kymera
- 02
- 03
- 04
- 05
Avalo Therapeutics to Participate in the BTIG Biotechnology Conference
AVTX · Source: Avalo Therapeutics
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of CalciMedica (CALC)?
CalciMedica (CALC) most recently closed at 0.70 USD, a -7.45% move versus the previous session.
What is the market cap of CalciMedica (CALC)?
CalciMedica currently has a market capitalization of 12.6M USD on BioPharmSignal.
What does CalciMedica do?
CalciMedica is a biotechnology company focused on calcium-channel biology and inflammatory disease. Its story centers on using a targeted mechanism to address severe immune-mediated conditions.
On which exchange is CALC stock listed?
CalciMedica (CALC) is associated with NASDAQ, United States, Biopharma.
What is CalciMedica?
CalciMedica’s catalysts are calcium-signaling inflammation programs and any clinical update that clarifies whether the company can still build a viable development story.
Which conditions is CalciMedica targeting with CalciMedica?
CalciMedica is associated with inflammatory disease based on its company overview and current catalyst commentary.
How does CalciMedica describe recent progress with CalciMedica?
CalciMedica’s catalysts are calcium-signaling inflammation programs and any clinical update that clarifies whether the company can still build a viable development story.
What future catalysts are investors watching for CalciMedica?
CalciMedica’s catalysts are calcium-signaling inflammation programs and any clinical update that clarifies whether the company can still build a viable development story. The next step matters because the story remains early.